ArticleHemaSphere2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
Pierre Sesques et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.